These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 19685508

  • 21. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
    Zhang XH, Huang DP, Guo GL, Chen GR, Zhang HX, Wan L, Chen SY.
    BMC Cancer; 2008 Jan 13; 8():4. PubMed ID: 18190720
    [Abstract] [Full Text] [Related]

  • 22. Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer.
    Barnes NL, Warnberg F, Farnie G, White D, Jiang W, Anderson E, Bundred NJ.
    Br J Cancer; 2007 Feb 26; 96(4):575-82. PubMed ID: 17285134
    [Abstract] [Full Text] [Related]

  • 23. [Expression of tumor suppressor genes p16, p21 and p53 in a pair of lung adenocarcinoma cell lines with different metastasis potentials: Anip973 and AGZY83-a].
    Wang B, Yan C, Wu Y, Gao H, Wang Q, Jin Y, Huang C, Zhang G, Fu S, Li P.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr 26; 18(2):128-31. PubMed ID: 11295133
    [Abstract] [Full Text] [Related]

  • 24. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival.
    Chen Z, Varney ML, Backora MW, Cowan K, Solheim JC, Talmadge JE, Singh RK.
    Cancer Res; 2005 Oct 01; 65(19):9004-11. PubMed ID: 16204074
    [Abstract] [Full Text] [Related]

  • 25. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
    Ninomiya I, Nagai N, Oyama K, Hayashi H, Tajima H, Kitagawa H, Fushida S, Fujimura T, Ohta T.
    Oncol Rep; 2012 Sep 01; 28(3):777-84. PubMed ID: 22751903
    [Abstract] [Full Text] [Related]

  • 26. Molecular control of lymphatic metastasis.
    Achen MG, Stacker SA.
    Ann N Y Acad Sci; 2008 Sep 01; 1131():225-34. PubMed ID: 18519975
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
    Majumder M, Xin X, Liu L, Girish GV, Lala PK.
    Cancer Sci; 2014 Sep 01; 105(9):1142-51. PubMed ID: 24981602
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice.
    Yanai Y, Furuhata T, Kimura Y, Yamaguchi K, Yasoshima T, Mitaka T, Mochizuki Y, Hirata K.
    J Exp Clin Cancer Res; 2001 Sep 01; 20(3):419-28. PubMed ID: 11718224
    [Abstract] [Full Text] [Related]

  • 31. [Effect of selective cyclooxygenase-2 inhibitor celebrex on expression of vascular endothelial growth factor (VEGF) in pancreatic carcinoma].
    Xie CG, Wang XP, Dong YW, Cai JT, Qian KD.
    Ai Zheng; 2003 Oct 01; 22(10):1042-6. PubMed ID: 14558947
    [Abstract] [Full Text] [Related]

  • 32. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
    Kang KB, Wang TT, Woon CT, Cheah ES, Moore XL, Zhu C, Wong MC.
    Int J Radiat Oncol Biol Phys; 2007 Mar 01; 67(3):888-96. PubMed ID: 17293239
    [Abstract] [Full Text] [Related]

  • 33. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
    Issa A, Le TX, Shoushtari AN, Shields JD, Swartz MA.
    Cancer Res; 2009 Jan 01; 69(1):349-57. PubMed ID: 19118020
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z, Scholz A, Stacker SA, Achen MG, Jackson DG, Alves F, Schirner M, Haberey M, Thierauch KH, Wiedenmann B, Rosewicz S.
    Int J Oncol; 2005 Sep 01; 27(3):669-79. PubMed ID: 16077915
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.